Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Correct. In the Zacks Small-Cap Research April 21st article by Jason Napodano: "RVX: Initiating Coverage of Resverlogix Corp.: A Clinical Stage Cardiovascular Company with an Epigenetics Platform" it was stated that Resverlogix was meeting with the European Medicines Agency in April and the FDA in May.
